Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2006-06-30
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults
NCT05764824
The Effect of Blueberry Supplementation on Cognitive Functioning in Older Adults
NCT07170943
Effects of Blueberry on Cognition and Mobility in Older Adults
NCT01888848
An Investigation Into the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults
NCT02446314
Effect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline
NCT01515098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
grape juice active intervention
Concord grape juice administered daily for 12 or 16 weeks
Concord grape juice
Several ounces Concord grape juice administered 3 times a day for 12 or 16 weeks. Specific dosage determined by participant's weight.
juice placebo
berry placebo juice administered daily for 12 or 16 weeks
placebo juice
several ounces placebo juice consumed three times a day for 12 or 16 weeks; dosage determined according to participant's weight
blueberry juice active intervention
wild blueberry juice administered daily for 12 weeks
blueberry juice
wild blueberry juice administered daily for 12 weeks, dosage determined according to participant's weight
blueberry powder intervention
whole fruit blueberry powder administered daily for 16 weeks
whole fruit blueberry powder
whole fruit, freeze dried blueberry powder derived from a blend of cultivated blueberries administered daily for 16 weeks
powder placebo
placebo powder administered daily for 16 weeks
berry placebo powder
berry placebo powder administered daily for 16 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Concord grape juice
Several ounces Concord grape juice administered 3 times a day for 12 or 16 weeks. Specific dosage determined by participant's weight.
placebo juice
several ounces placebo juice consumed three times a day for 12 or 16 weeks; dosage determined according to participant's weight
blueberry juice
wild blueberry juice administered daily for 12 weeks, dosage determined according to participant's weight
whole fruit blueberry powder
whole fruit, freeze dried blueberry powder derived from a blend of cultivated blueberries administered daily for 16 weeks
berry placebo powder
berry placebo powder administered daily for 16 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Weight of under 100 or over 210 pounds
* Chronic use of pain medication
66 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Welch Foods Incorporated
INDUSTRY
U.S. Highbush Blueberry Council
OTHER
University of Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Krikorian
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Krikorian, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cincinnati
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-03-20-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.